Home LiteratureArticle Details
PMID: 1992764 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.

The American journal of pathology ·Vol. 138 ·No. 2 ·1991-02-00 ·Pages 395-402

Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL

Abstract

Using a model of sepsis induced by parenteral challenge of mice with bacterial lipopolysaccharide (LPS), the authors analyzed the in vivo expression of interleukin-1 (IL-1) alpha,beta and tumor necrosis factor (TNF). Both TNF and IL-1 alpha,beta were detected in hepatic sinusoidal macrophages (Kupffer cells), immunohistochemically. Kinetic analysis showed a clear sequence of synthesis. Tumor necrosis factor was produced first, reaching maximal expression at 1 hour after LPS challenge, then rapidly disappeared. IL-1 beta followed, reaching maximal expression at 2 to 3 hours, then dropped off by 6 hours. Interleukin-1 alpha expression reached a peak at 6 hours and had disappeared by 18 hours. Analysis of serum bioactivity also revealed sequential expression that correlated with immunohistochemical findings. Tumor necrosis factor was maximal at 1 hour and IL-1 at 6 hours. The IL-1 bioactivity was not due to interleukin-6 (IL-6), as this was depleted from specimens by immunoabsorption. Also IL-6 bioactivity reached maximal levels at 3 hours, earlier than IL-1. Pretreatment with 4 mg/kg dexamethasone significantly decreased Kupffer cell expression of TNF and IL-1 alpha (about 80% and 60% suppression, respectively) but had less effect on IL-1 beta expression (about 30% suppression). Accordingly, serum levels of TNF were suppressed by 75% while serum IL-1 was decreased by 39%, indicating differential sensitivity of these cytokines to glucocorticoids. Endogenous corticosteroid levels increased as TNF levels decreased, supporting the contention that glucocorticoids regulate TNF synthesis. In contrast, IL-1 levels rose concurrently with corticosterone. These data indicate a sequential activation of cytokine gene expression in vivo, which may be critical to the cascade of events leading to septic shock, and provide evidence that Kupffer cells are a major source of cytokines in endotoxemia. Finally, the differential sensitivity of cytokine expression to glucocorticoids may in part explain the inadequacy of the latter in the treatment of sepsis.

MeSH Terms
Animals Corticosterone/blood Dexamethasone/pharmacology Endotoxins/blood Escherichia coli Immunohistochemistry Interleukin-1/blood,metabolism Interleukin-6/blood Kinetics Kupffer Cells/metabolism Lipopolysaccharides/pharmacology Mice Mice, Inbred Strains Tumor Necrosis Factor-alpha/metabolism
Chemicals
Endotoxins Interleukin-1 Interleukin-6 Lipopolysaccharides Tumor Necrosis Factor-alpha Dexamethasone Corticosterone
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Chensue S W
Department of Pathology, Veterans Affairs Medical Center, Ann Arbor, MI 48105.
Terebuh P D
Remick D G
Scales W E
Kunkel S L
References (28)
28 references, click to expand
  1. Evidence for the identification of lymphocyte activating factor as the adherent cell-derived mediator responsible for enhanced antibody synthesis by nude mouse spleen cells.
    Cell Immunol. 1978 Jan;35(1):92-8 PMID: 620430
  2. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.
    Immunol Invest. 1990 Feb;19(1):69-79 PMID: 2110931
  3. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
    Science. 1986 May 23;232(4753):977-80 PMID: 3754653
  4. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.
    Science. 1986 Aug 8;233(4764):652-4 PMID: 3014662
  5. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    J Immunol Methods. 1986 Dec 4;95(1):99-105 PMID: 3782828
  6. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
    N Engl J Med. 1987 Sep 10;317(11):653-8 PMID: 3306374
  7. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  8. Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone.
    J Immunol. 1988 Mar 15;140(6):1895-902 PMID: 3257992
  9. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  10. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
    J Exp Med. 1988 Jul 1;168(1):443-8 PMID: 3260938
  11. In vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone.
    J Immunol. 1988 Sep 1;141(5):1456-63 PMID: 3261749
  12. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.
    Eur J Immunol. 1988 Aug;18(8):1259-64 PMID: 3138137
  13. Tumor necrosis factor and the acute metabolic response to tissue injury in man.
    J Clin Invest. 1988 Oct;82(4):1321-5 PMID: 3139712
  14. Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages.
    Am J Pathol. 1988 Dec;133(3):564-72 PMID: 3202118
  15. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    J Exp Med. 1989 Jan 1;169(1):333-8 PMID: 2783334
  16. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.
    Eur J Immunol. 1989 Feb;19(2):301-5 PMID: 2784766
  17. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.
    J Leukoc Biol. 1989 May;45(5):416-21 PMID: 2651547
  18. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
    Pharm Res. 1988 Mar;5(3):129-39 PMID: 3072553
  19. The beta form is the dominant interleukin 1 released by murine peritoneal macrophages.
    Biochem Biophys Res Commun. 1989 Apr 14;160(1):404-8 PMID: 2653321
  20. Kinetics and parameters of the induction of interleukin 1 secretion by rat Kupffer cells.
    J Clin Lab Immunol. 1988 Nov;27(3):127-32 PMID: 2854570
  21. IL-6 is an intermediate in IL-1-induced thymocyte proliferation.
    J Immunol. 1989 Jun 15;142(12):4335-8 PMID: 2786028
  22. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression.
    Lab Invest. 1989 Jun;60(6):766-71 PMID: 2733382
  23. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models.
    Infect Immun. 1989 Oct;57(10):3009-13 PMID: 2777371
  24. Biologic and immunohistochemical analysis of macrophage interleukin- 1 alpha, - 1 beta, and tumor necrosis factor production during the peritoneal exudative response.
    J Leukoc Biol. 1989 Dec;46(6):529-37 PMID: 2809418
  25. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    J Exp Med. 1989 Nov 1;170(5):1627-33 PMID: 2809510
  26. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.
    J Exp Med. 1989 Dec 1;170(6):1859-67 PMID: 2584928
  27. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.
    Am J Pathol. 1990 Jan;136(1):49-60 PMID: 2297050
  28. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.
    J Immunol. 1978 May;120(5):1497-503 PMID: 149171
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1991-02-00
Pages
395-402
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1886197
Subset
IM
Grants
NHLBI NIH HHS · HL31237 · United States
NHLBI NIH HHS · HL31963 · United States
NHLBI NIH HHS · HL35276 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com